These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24345349)

  • 61. [Evaluation of antidepressant use in the basque country during the period 2000-2006].
    Prieto Blanco M; Elizondo López De Landache I; Braceras Izaguirre L
    Aten Primaria; 2009 Feb; 41(2):124-6. PubMed ID: 19231713
    [No Abstract]   [Full Text] [Related]  

  • 62. Cross-sectional survey of patients in receipt of long-term repeat prescriptions for antidepressant drugs in primary care.
    Cruickshank G; Macgillivray S; Bruce D; Mather A; Matthews K; Williams B
    Ment Health Fam Med; 2008 Jun; 5(2):105-9. PubMed ID: 22477855
    [TBL] [Abstract][Full Text] [Related]  

  • 63. QuickStats: Percentage of Adults Aged ≥20 Years Who Used Antidepressant Medications* in the Past 30 Days, by Sex and Marital Status - National Health and Nutrition Examination Survey, United States, 2015-2018.
    MMWR Morb Mortal Wkly Rep; 2020 Oct; 69(42):1555. PubMed ID: 33090986
    [No Abstract]   [Full Text] [Related]  

  • 64. Employers Engaged in Benefit Design Innovation: Long-Term Trends in a 2015 National Survey.
    Larson C; Vogenberg FR
    Am Health Drug Benefits; 2015 Dec; 8(9):490-2. PubMed ID: 26834935
    [No Abstract]   [Full Text] [Related]  

  • 65. Altered brain correlates of response inhibition and error processing in females with obesity and sweet food addiction: A functional magnetic imaging study.
    Hsu JS; Wang PW; Ko CH; Hsieh TJ; Chen CY; Yen JY
    Obes Res Clin Pract; 2017; 11(6):677-686. PubMed ID: 28552670
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prenatal androgen exposure and children's aggressive behavior and activity level.
    Spencer D; Pasterski V; Neufeld S; Glover V; O'Connor TG; Hindmarsh PC; Hughes IA; Acerini CL; Hines M
    Horm Behav; 2017 Nov; 96():156-165. PubMed ID: 28939371
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.
    Solmi M; Fornaro M; Ostinelli EG; Zangani C; Croatto G; Monaco F; Krinitski D; Fusar-Poli P; Correll CU
    World Psychiatry; 2020 Jun; 19(2):214-232. PubMed ID: 32394557
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials.
    Sim K; Lau WK; Sim J; Sum MY; Baldessarini RJ
    Int J Neuropsychopharmacol; 2015 Jul; 19(2):. PubMed ID: 26152228
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacoeconomic implications of preference toward reference- versus generic-brand antidepressants in primary care.
    Gultekin O; Aydin V; Bayram D; Atac O; Akici A
    Prim Health Care Res Dev; 2024 Sep; 25():e40. PubMed ID: 39301599
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Potential deprescribing indications for antidepressants between 2012 and 2019: repeated cross-sectional analysis in two Scottish health boards.
    Brisnik V; Rottenkolber M; Vukas J; Schechner M; Lukaschek K; Jung-Sievers C; Gensichen J; Thiem U; Drey M; Krüger N; Mair A; Guthrie B; Fischer S; Dreischulte T;
    BMC Med; 2024 Sep; 22(1):378. PubMed ID: 39256761
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis.
    Kamp CB; Petersen JJ; Faltermeier P; Juul S; Siddiqui F; Barbateskovic M; Kristensen AT; Moncrieff J; Horowitz MA; Hengartner MP; Kirsch I; Gluud C; Jakobsen JC
    BMJ Ment Health; 2024 Jan; 27(1):. PubMed ID: 39093721
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevalence and trends in overactive bladder among men in the United States, 2005-2020.
    Cheng Y; Chen T; Zheng G; Song Z; Zhang G; Rao X; Zeng T; Yuan C
    Sci Rep; 2024 Jul; 14(1):16284. PubMed ID: 39009696
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Internet and Telephone Support for Discontinuing Long-Term Antidepressants: The REDUCE Cluster Randomized Trial.
    Kendrick T; Stuart B; Bowers H; Haji Sadeghi M; Page H; Dowrick C; Moore M; Gabbay M; Leydon GM; Yao GL; Little P; Griffiths G; Lewis G; May C; Moncrieff J; Johnson CF; Macleod U; Gilbody S; Dewar-Haggart R; Williams S; O'Brien W; Tiwari R; Woods C; Patel T; Khan N; van Ginneken N; Din A; Reidy C; Lucier R; Palmer B; Becque T; van Leeuwen E; Zhu S; Geraghty AWA
    JAMA Netw Open; 2024 Jun; 7(6):e2418383. PubMed ID: 38913372
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method.
    Brisnik V; Vukas J; Jung-Sievers C; Lukaschek K; Alexander GC; Thiem U; Thürmann P; Schüle C; Fischer S; Baum E; Drey M; Harder S; Niebling W; Janka U; Krause O; Gensichen J; Dreischulte T;
    BMC Med; 2024 May; 22(1):193. PubMed ID: 38735930
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Understanding Australian general practice patients' decisions to deprescribe antidepressants in the WiserAD trial: a realist informed approach.
    Coe A; Gunn J; Allnutt Z; Kaylor-Hughes C
    BMJ Open; 2024 Feb; 14(2):e078179. PubMed ID: 38355180
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Improving patient experience for people prescribed medicines with a risk of dependence or withdrawal: co-designed solutions using experience based co-design.
    Seddon J; Friedrich C; Wadd S; Dicks D; Scott S; Robinson A; Walker C
    BMC Prim Care; 2024 Jan; 25(1):17. PubMed ID: 38184517
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report.
    Wu J; Yu J; Qu K; Yin J; Zhu C; Liu X
    Front Psychiatry; 2023; 14():1257984. PubMed ID: 37886119
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Provision of Cognitive Behavior Therapy for Depression and Anxiety Disorders by Medical Student Trainees.
    Powell SK; Serafini RA; Frere JJ; De Pins A; Saali A; Sultana SA; Ali M; Dale B; Datta D; Aaronson C; Meah Y; Katz CL; Gluhoski V
    Acad Psychiatry; 2024 Feb; 48(1):10-17. PubMed ID: 37770702
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys.
    Kazdin AE; Harris MG; Hwang I; Sampson NA; Stein DJ; Viana MC; Vigo DV; Wu CS; Aguilar-Gaxiola S; Alonso J; Benjet C; Bruffaerts R; Caldas-Almeida JM; Cardoso G; Caselani E; Chardoul S; Cía A; de Jonge P; Gureje O; Haro JM; Karam EG; Kovess-Masfety V; Navarro-Mateu F; Piazza M; Posada-Villa J; Scott KM; Stagnaro JC; Ten Have M; Torres Y; Vladescu C; Kessler RC;
    Psychol Med; 2024 Jan; 54(1):67-78. PubMed ID: 37706298
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Supporting antidepressant discontinuation using mindfulness plus monitoring versus monitoring alone: A cluster randomized trial in general practice.
    Huijbers MJ; Wentink C; Lucassen PLBJ; Kramers C; Akkermans R; Spijker J; Speckens AEM
    PLoS One; 2023; 18(9):e0290965. PubMed ID: 37669281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.